Concurrent allergic diseases were seen in 5 (27.8%) patients with EoE and 16 (69.6%) with EGE, showing a significantly higher rate for EGE (P < 0.01) (Table 1). Bronchial asthma and food allergies ...

This article was originally published on Dermatology Times ®. It has been lightly edited. Regardless of dosing interval, dupilumab successfully and steadily reduces immunoglubulin E (IgE) serum levels ...

Please provide your email address to receive an email when new articles are posted on . Elevated IgE levels in cord blood predicted allergic sensitization, airway inflammation and asthma among ...

BROOKLYN — A SUNY DOWNSTATE study published in the Journal of Allergy and Clinical Immunology found that elevated levels of serum immunoglobulin E (IgE) – a blood antibody responsible for many ...

Medically reviewed by Jurairat J. Molina, MD Key Takeawyas High IgE levels can be associated with various conditions, including allergies, allergic asthma, infections, and autoimmune disorders. High ...

This study was prompted by recent findings that ultra-low IgE levels (IgE <2.5 kU/L) may be linked with a higher risk of cancers. A recent study sought to investigate the effect on IgE levels when ...

Please provide your email address to receive an email when new articles are posted on . The measurement of immunoglobulin E levels in children hospitalized for atopic dermatitis exacerbation or ...

Treatment with omalizumab offers modest protection from allergic reactions to individuals with multiple food allergies, and baseline immunoglobulin E (Ig E) levels are associated with success, based ...

Whereas natural tolerance rates are generally high for common allergens, such as eggs, milk, and wheat, allergies to other foods often persist beyond childhood. For instance, approximately 72.2% of ...

The preclinical pharmacokinetic (PK) and pharmacodynamic (PD) studies, conducted in cynomolgus monkeys following subcutaneous and intravenous administration, demonstrated rapid downregulation of the ...

Extension financing adds new investors, Janus Henderson Investors and RA Capital, with strong renewed participation ...

HAMPTON, N.J., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Celldex (NASDAQ:CLDX) announced today new data demonstrating rapid and strong efficacy regardless of baseline immunoglobulin E (IgE) levels in ...